Skip to main content

Month: April 2021

Wereldhave Trading Update Q1 2021

Benelux disposal program almost completed EUR 32m new financing arranged; expected to secure liquidity until Q3 2023 soon Shopping center occupancy relatively stable at 94% Successful delivery of FSC concepts in 2020 pushes NPS score to +9 from +4 Outlook for 2021 direct result per share at the lower end of the previous guidance of € 1.80 – 2.00AttachmentWereldhave Trading Update Q1 2021

Continue reading

Corbion appoints Aurélie Dalbiez as Chief Human Resources Officer

Corbion announces the appointment of Aurélie Dalbiez as Chief Human Resources Officer and member of the Executive Committee as of 1 July 2021.Mrs. Dalbiez (a French national) currently is Head of HR for the Capsules and Health Ingredients business at Lonza, based in Basel, Switzerland. Prior to that, she worked for 12 years in various HR roles at Novartis. She started her career at Deutsche Bank before working for Capital International, a global investment company. CEO Olivier Rigaud commented: “I am really pleased to welcome Aurélie to the ExCo team as a seasoned HR leader who partners closely with the business to develop talent, drive culture, engagement, continuous improvement, and customer intimacy. Her appointment will also further enhance the diversity of our ExCo.” Mrs. Dalbiez brings a multi-cultural background and...

Continue reading

GrandVision reports 1Q21 revenue of €899 million and adjusted EBITA of €79 million

GrandVision reports 1Q21 revenue of €899 million and adjusted EBITA of €79 million Schiphol, the Netherlands – 23 April 2021. GrandVision N.V. publishes its First Quarter 2021 trading update. Due to the exceptional nature of the year 2020, GrandVision will also include in the present press release comparisons versus 2019. Highlights • GrandVision continues to show resilience in the first quarter despite the most recent COVID-19 related government restrictions in Europe and Latam • At constant exchange rates, revenue declined by -0.7% compared with 1Q20 to €899 million from €926 million in 1Q20 (1Q19: €974m) • Comparable revenue declined by -1.5% versus 1Q20 and on a 2019 basis, -10.8% versus 1Q19 • Adj. EBITA increased by 98.1% at constant exchange rates to €79 million from €41 million in 1Q20 (1Q19: €107m). Continued cost discipline,...

Continue reading

Corbion benoemt Aurélie Dalbiez tot Chief Human Resources Officer

Corbion maakt de benoeming bekend van Aurélie Dalbiez tot Chief Human Resources Officer en lid van het Executive Committee van Corbion, ingaande 1 juli 2021. Mevr. Dalbiez heeft de Franse nationaliteit en is momenteel hoofd HR van de Capsules and Health Ingredients business van het in Basel, Zwitserland gevestigde Lonza. Daarvoor werkte zij gedurende 12 jaar in diverse HR-functies voor Novartis. Zij startte haar carrière bij Deutsche Bank en werkte daarna bij Capital International, een wereldwijd opererende investeringsfirma. CEO Olivier Rigaud: “Het verheugt mij zeer dat ik Aurélie welkom mag heten als lid van het ExCo-team. Zij is een zeer ervaren HR-professional die in nauwe samenwerking met de business talent ontwikkelt en zich sterk maakt voor de bedrijfscultuur, betrokkenheid, continue verbetering en hechte klantcontacten. Haar...

Continue reading

AS Tallinna Vesi will hold an Investor Conference Webinar to introduce the results for the 1st quarter of 2021

AS Tallinna Vesi invites its shareholders, investors, analysts and other stakeholders to join its investor conference webinar, introducing the results for the first quarter of 2021.The webinar is scheduled for 30 April 2021 at 11:00 am (EET) and will be held in English. The webinar will be hosted by Kristi Ojakäär, Chief Financial Officer, and Aleksandr Timofejev, Chief Operations Officer. The questions will be answered by Kristi Ojakäär and Aleksandr Timofejev after the presentation. We encourage participants to send their questions before the webinar takes place, by 9:00 am (EET) on April 30 at the latest, to laura.korjus@tvesi.ee. Questions can also be asked during the webinar. To join the webinar, please register via following link: https://attendee.gotowebinar.com/register/7965867599439776781. The registration will be open until...

Continue reading

AS Tallinna Vesi korraldab 2021. aasta esimese kvartali tulemuste tutvustamiseks veebiseminari

Tallinna Vesi kutsub aktsionäre, investoreid, analüütikuid ja teisi huvilisi osalema ettevõtte 2021. aasta esimese kvartali tulemusi tutvustaval veebiseminaril 30. aprillil 2021 kell 11.00. Veebiseminar toimub inglise keeles. Tulemusi tutvustavad finantsdirektor Kristi Ojakäär ja tootmisdirektor Aleksandr Timofejev. Kristi Ojakäär ja Aleksandr Timofejev vastavad küsimustele pärast presentatsiooni. Soovitame küsimused saata enne veebiseminari toimumist hiljemalt 30. aprillil kella 9.00-ks e-kirja teel: laura.korjus@tvesi.ee. Küsimusi saab esitada ka veebiseminari ajal. Veebiseminaril osalemiseks palume registreeruda siin: https://attendee.gotowebinar.com/register/7965867599439776781. Registreerumine on avatud 30. aprillil kuni kella 9.00-ni. Teile saadetakse link veebiseminarile ja juhised keskkonna kasutamiseks. Kui osalete veebiseminaril...

Continue reading

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

About 90,000 women globally die from endometrial cancer each year1 VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI (dostarlimab-gxly) Roche/GSK collaboration represents an important step towards a personalised healthcare strategy that can help identify patients who are most likely to benefit from a specific therapyBasel, 23 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel for advanced or recurrent endometrial cancer patients. MMR is a molecular mechanism that functions to correct certain errors that can spontaneously occur during DNA replication. Testing can identify patients eligible for treatment with JEMPERLI (dostarlimab-gxly) monotherapy,...

Continue reading

INTERIM REPORT for 1 January – 31 March 2021: Verkkokauppa.com’s revenue grew and profitability improved along with strong online sales

INTERIM REPORT for 1 January – 31 March 2021: Verkkokauppa.com’s revenue grew and profitability improved along with strong online sales Verkkokauppa.com Oyj – Interim report 23 April 2021, 8:00 a.m. Verkkokauppa.com arranges two news conferences today. News conference in Finnish is held at 10:00 am Finnish time. Another news conference for analysts and institutional investors is in English is at 11:00 am Finnish time. Details of the events can be found at the end of this release. The complete report is attached to this release and also available at https://investors.verkkokauppa.com/en Unless otherwise stated, the comparison figures in brackets refer to the corresponding period in the previous year (reference period). Figures are unaudited. 1 January – 31 March 2021 in briefRevenue was 134 million euros (125) Gross profit was 21.7 million...

Continue reading

Verkkokauppa.com decided on the payment of quarterly dividend

Verkkokauppa.com Oyj Stock Exchange Release 23 April 2021 at 7:45 EET Verkkokauppa.com decided on the payment of quarterly dividend The Board of Directors of Verkkokauppa.com Oyj has decided today, on the basis of the authorization granted by the Annual General Meeting 2021, that a dividend of EUR 0.057 per share (in total EUR 2,549,581.33 in total) be distributed from retained earnings. The dividend will be paid to a shareholder registered in the company’s shareholders’ register maintained by Euroclear Finland Ltd on the record date for the dividend on 27 April 2021. The dividend will be paid on 4 May 2021. Verkkokauppa.com’s Annual General Meeting, held on 25 March 2021, resolved to authorize the Board of Directors to decide at its discretion on the distribution of dividends. Based on the authorization, the total amount of the quarterly...

Continue reading

Verkkokauppa.com päätti kvartaaliosingon jakamisesta

Verkkokauppa.com Oyj PÖRSSITIEDOTE 23.4.2021 klo 07.45 Verkkokauppa.com päätti kvartaaliosingon jakamisesta Verkkokauppa.com Oyj:n hallitus päätti tänään vuoden 2021 varsinaiselta yhtiökokoukselta saamansa valtuutuksen perusteella, että yhtiön kertyneistä voittovaroista jaetaan osinkoa 0,057 euroa osakkeelta (yhteensä 2 549 581,33 euroa). Osinko maksetaan osakkeenomistajalle, joka on osingon täsmäytyspäivänä 27.4.2021 merkittynä Euroclear Finland Oy:n pitämään yhtiön osakasluetteloon. Osinko maksetaan 4.5.2021. Verkkokauppa.comin 25.3.2021 pidetty varsinainen yhtiökokous päätti valtuuttaa hallituksen päättämään harkintansa mukaan osingonjakamisesta. Valtuutuksen perusteella neljänneksittäin jaettavan osingon määrä on yhteensä enintään 0,174 euroa osakkeelta. Ellei hallitus päätä toisin tai Suomen arvo-osuusjärjestelmän säädöksien tai...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.